Static Chart CEL-SCI Corporation

Equities

Market Closed - Nyse Other stock markets 04:00:00 2024-05-13 pm EDT			5-day change	1st Jan Change
1.42 ^USD	0.00%		-17.44%	-47.79%

May. 08	Cel-Sci Gets US FDA Clearance to Proceed With Confirmatory Study for Cancer Drug Multikine	MT
May. 08	CEL-SCI Corporation Announces Significantly Positive Outcome from its Recent Meeting with U.S. Food and Drug Administration Regarding Path to Approval for its First-Line Investigational Cancer Immunotherapy Multikine	CI

Duration

Period